CompletedNot Applicable

Cera™ VSD Occluder Post Market Clinical Follow-up

Taiwan152 participantsStarted 2023-10-13

Plain-language summary

The objective of this post-market registry is to assess the safety and performance of the Lifetech Cera™ VSD occluder in a real-world and on-label fashion.

Who can participate

Age range3 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with a confirmed diagnosis of Ventricular Septal Defect (VSD) and implanted with the investigational device as per IFU instructions Exclusion Criteria: * Patients did not conduct any follow up visit after hospital discharge.

What they're measuring

Procedural success

Timeframe: 6 months post-implantation

Trial details

NCT IDNCT05939713

SponsorCardiac Children's Foundation Taiwan

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-03-04

View on ClinicalTrials.gov More Ventricular Septal Defect trials